Liverpool to lead national healthcare research Hub for Advanced Long-acting Therapeutics
https://news.liverpool.ac.uk/2…A new national research hub, led by the University of Liverpool, will position the UK as a world leader in the emerging global field of long-acting therapeutics (LATs).
The image credit to: University of Liverpool
Supported with an £11 million grant from the Engineering and Physical Sciences Research Council (EPSRC), the Hub for Advanced Long-acting Therapeutics (HALo) will drive research, public and patient engagement, and the translational infrastructure required for the development and manufacture of new LATs to ensure the UK is at the forefront of this strategically important healthcare area.
Long-acting therapeutics (LATs)
LATs are set to revolutionise how we treat diseases and manage health conditions by replacing weeks or even months of pill taking with a single administered dose.
Already available in the fields of contraception, HIV therapy, and the management of mental health conditions, this new approach addresses the issue of missed daily drug doses which can cause a range of complications from a lack of efficacy to pathogen resistance. Read more
Let’s innovate together
To find out more about how we can work together, please enter your details below. More contact options